HIV viral set point and host immune control in individuals with HIV-specific CD8+ T-cell responses prior to HIV acquisition

AIDS

Volumn 24, Issue 10, 2010, Pages 1449-1454

  Kaul, Rupert ^a,b,c   MacDonald, Kelly S ^a,c,d   Nagelkerke, Nico J ^e   Kimani, Joshua ^b,f   Fowke, Keith ^b,f   Ball, T Blake ^b,f,h   Luo, Ma ^f,h   Kariri, Anthony ^b   Jaoko, Walter ^b   Moses, Stephen ^f   Rowland Jones, Sarah ^g,h   Plummer, Francis A ^f,h  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^f PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^g PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^h UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CD8+ T cell; female sex worker; highly exposed; HIV; immune control; persistently seronegative; viral load

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON;

ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COHORT ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; LYSIS; POST HOC ANALYSIS; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS LOAD; WORKER;

CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; KENYA; LYMPHOCYTE ACTIVATION; PROSTITUTION; VIRAL LOAD;

EID: 77953911299     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283391d40     Document Type: Article

References (24)

1. Letvin NL. Correlates of immune protection and the development of a human immunodeficiency virus vaccine. Immunity 2007; 27:366-369.
2. Letvin NL, Barouch DH, Montefiori DC. Prospects for vaccine protection against HIV-1 infection and AIDS. Annu Rev Immunol 2002; 20:73-99.
3. McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 2008; 372:1894-1905.
4. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008; 372: 1881-1893.
5. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361:2209-2220.
6. Pantaleo G, Koup RA. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat Med 2004; 10:806-810.
7. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348:1347-1351.
8. Hirbod T, Kaul R, Reichard C, Kimani J, Ngugi E, Bwayo JJ, et al. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS 2008; 22:727-735.
9. Kaul R, Rutherford J, Rowland-Jones SL, Kimani J, Onyango JI, Fowke K, et al. HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis. AIDS 2004; 18:2087-2089.
10. Kaul R, Rowland-Jones SL, Kimani J, Dong T, Yang HB, Kiama P, et al. Late seroconversion in HIV-resistant Nairobi prostitutes despite pre existing HIV-specific CD8(R) responses. J Clin Invest 2001; 107:341-349.
11. Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Ngugi EN, Keli F, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 2004; 291:2555-2562.
12. Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Keli F, MacDonald KS, et al. Reduced HIV risk-taking and low HIV incidence after enrollment and risk-reduction counseling in a sexually transmitted disease prevention trial in Nairobi, Kenya. J Acquir Immune Defic Syndr 2002; 30:69-72.
13. Ngugi EN, Wilson D, Sebstad J, Plummer FA, Moses S. Focused peer-mediated educational programs among female sex workers to reduce sexually transmitted disease and human immunodeficiency virus transmission in Kenya and Zimbabwe. J Infect Dis 1996; 174 (Suppl 2):S240-247.
14. Luo M, Mao X, Plummer FA. Identification of four novel HLA-B alleles, BM1590, BM1591, BM2726, and BM4705, from an East African population by high-resolution sequence-based typing. Tissue Antigens 2005; 65:187-191.
15. Fowke KR, Kaul R, Rosenthal KL, Oyugi J, Kimani J, Rutherford WJ, et al. HIV-1-specific cellular immune responses among HIV-1-resistant sex workers. Immunol Cell Biol 2000; 78:586-595.
16. Kaul R, Dong T, Plummer FA, Kimani J, Rostron T, Kiama P, et al. CD8(R) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest 2001; 107:1303-1310.
17. R lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 2000; 164:1602-1611.
18. Kaul R, Rowland-Jones SL, Kimani J, Fowke K, Dong T, Kiama P, et al. New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 2001; 79:3-13.
19. Sheth PM, Sunderji S, Shin LY, Rebbapragada A, Huibner S, Kimani J, et al. Co-infection with Herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. J Infect Dis 2008; 197:1394-1401.
20. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, Newell H, et al. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998; 102:1758-1765.
21. Ball TB, Ji H, Kimani J, McLaren P, Marlin C, Hill AV, Plummer FA. Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 2007; 21:1091-1101.
22. Card CM, McLaren PJ, Wachihi C, Kimani J, Plummer FA, Fowke KR. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(R)CD25(R)FOXP3(R) regulatory T cells. J Infect Dis 2009; 199:1318-1322.
23. Heckerman D, Frahm N, Pereyra F, Dubey S, Geraghty D, Carlson JM, et al. Vaccine-induced targeting of epitopes associated with spontaneous control of HIV viral replication is associated with lower set-point viral loads in HIV-infected participants from the STEP trial [abstract #242]. HIV Immuno-biology from Infection to Immune Control, 22-27 March 2009; Keystone, Colorado, USA.
24. Dolin R. HIV vaccine trial results: an opening for further research. N Engl J Med 2009; 361:2279-2280.